Latest News & PR
The publication “Empty mesoporous silica particles significantly delay disease progression and extend survival in a mouse model of ALS” has been published in Nature Research Scientific Reports, Nov 26, 2020. The publication relates to Nanologica’s patent application “Porous particles for use in treatment, prevention and/or postponement of degeneration of neurons and glia” that became public
Today at approximately 15.20, CEO Andreas Bhagwani will present Nanologica at Erik Penser Bank Company Day. The presentation can be followed live here. For more information and schedule of presenting companies, please visit Erik Penser Bank.
Nanologica is a public company listed for trade on Spotlight Stock Market. For information regarding financial reports, press releases, presentations and share holder information, please visit our investor relations section.
Presentation of Nanologica
Company presentation made by CEO Andreas Bhagwani on May 28, 2019.
For more videos about the Company as well as video presentations of interim reports, please refer to Investor Relations.